# Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

> **NCT06979323** · PHASE3 · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 150 (estimated)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** Depemokimab

## Key facts

- **NCT ID:** NCT06979323
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-03
- **Primary completion:** 2027-12-08
- **Final completion:** 2028-02-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979323, "Depemokimab Asthma Imaging and Bronchoscopy Sub-Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06979323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*